Home Top Stories A patient taking erythromycin develops an unusually high plasma concentration

A patient taking erythromycin develops an unusually high plasma concentration

4
27

A patient taking erythromycin develops an unusually high plasma concentration

1. A patient taking erythromycin develops an unusually high plasma concentration of a concurrently administered drug that is primarily metabolised by CYP3A4. What best explains this interaction?
A. Increased plasma protein synthesis
B. Induction of CYP3A4 activity
C. Inhibition of CYP3A4 activity
D. Activation of renal drug secretion

2. A drug exhibits a narrow therapeutic index and undergoes extensive first-pass metabolism. Which route of administration most directly avoids hepatic first-pass metabolism while still allowing systemic absorption?
A. Rectal administration
B. Intraperitoneal administration
C. Oral administration
D. Sublingual administration

4 COMMENTS

LEAVE A REPLY

Please enter your comment!
Please enter your name here